169 related articles for article (PubMed ID: 12175544)
1. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.
Kondo T; Ohta T; Igura K; Hara Y; Kaji K
Cancer Lett; 2002 Jun; 180(2):139-44. PubMed ID: 12175544
[TBL] [Abstract][Full Text] [Related]
2. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Tang FY; Nguyen N; Meydani M
Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
[TBL] [Abstract][Full Text] [Related]
3. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.
Lamy S; Gingras D; Béliveau R
Cancer Res; 2002 Jan; 62(2):381-5. PubMed ID: 11809684
[TBL] [Abstract][Full Text] [Related]
4. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
Tang FY; Chiang EP; Shih CJ
J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832
[TBL] [Abstract][Full Text] [Related]
5. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
6. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
8. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
9. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.
Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK
Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484
[TBL] [Abstract][Full Text] [Related]
10. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
[TBL] [Abstract][Full Text] [Related]
12. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
13. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
14. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
15. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production.
Tang FY; Meydani M
Nutr Cancer; 2001; 41(1-2):119-25. PubMed ID: 12094614
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells.
Yoo HG; Shin BA; Park JC; Kim HS; Kim WJ; Chay KO; Ahn BW; Park RK; Ellis LM; Jung YD
Anticancer Res; 2002; 22(6A):3373-8. PubMed ID: 12530089
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
18. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.
Kojima-Yuasa A; Hua JJ; Kennedy DO; Matsui-Yuasa I
Life Sci; 2003 Jul; 73(10):1299-313. PubMed ID: 12850245
[TBL] [Abstract][Full Text] [Related]
19. In vitro screening for angiostatic potential of herbal chemicals.
Cao L; Liu H; Lam DS; Yam GH; Pang CP
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6658-64. PubMed ID: 20671276
[TBL] [Abstract][Full Text] [Related]
20. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.
Maeda K; Kuzuya M; Cheng XW; Asai T; Kanda S; Tamaya-Mori N; Sasaki T; Shibata T; Iguchi A
Atherosclerosis; 2003 Jan; 166(1):23-30. PubMed ID: 12482547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
